GB0308382D0 - Therapeutic methods and means - Google Patents

Therapeutic methods and means

Info

Publication number
GB0308382D0
GB0308382D0 GB0308382A GB0308382A GB0308382D0 GB 0308382 D0 GB0308382 D0 GB 0308382D0 GB 0308382 A GB0308382 A GB 0308382A GB 0308382 A GB0308382 A GB 0308382A GB 0308382 D0 GB0308382 D0 GB 0308382D0
Authority
GB
United Kingdom
Prior art keywords
means
therapeutic methods
therapeutic
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0308382A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge University Technical Services Ltd (CUTS)
Original Assignee
Cambridge University Technical Services Ltd (CUTS)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge University Technical Services Ltd (CUTS) filed Critical Cambridge University Technical Services Ltd (CUTS)
Priority to GB0308382A priority Critical patent/GB0308382D0/en
Publication of GB0308382D0 publication Critical patent/GB0308382D0/en
Application status is Ceased legal-status Critical

Links

GB0308382A 2003-04-10 2003-04-10 Therapeutic methods and means Ceased GB0308382D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0308382A GB0308382D0 (en) 2003-04-10 2003-04-10 Therapeutic methods and means

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0308382A GB0308382D0 (en) 2003-04-10 2003-04-10 Therapeutic methods and means
PCT/GB2004/001546 WO2004089351A2 (en) 2003-04-10 2004-04-07 Treatment of progressive neurological disorders comprising a mao inhibitor (miclobemid) and an acetylcholinesterase inhibitor (tacrin)

Publications (1)

Publication Number Publication Date
GB0308382D0 true GB0308382D0 (en) 2003-05-21

Family

ID=9956617

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0308382A Ceased GB0308382D0 (en) 2003-04-10 2003-04-10 Therapeutic methods and means

Country Status (2)

Country Link
GB (1) GB0308382D0 (en)
WO (1) WO2004089351A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008104580A1 (en) 2007-03-01 2008-09-04 Probiodrug Ag New use of glutaminyl cyclase inhibitors
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
JP5523107B2 (en) 2006-11-30 2014-06-18 プロビオドルグ エージー Novel inhibitors of glutaminyl cyclase
WO2008128985A1 (en) 2007-04-18 2008-10-30 Probiodrug Ag Thiourea derivatives as glutaminyl cyclase inhibitors
RU2366430C2 (en) 2007-05-23 2009-09-10 Виктор Иванович Рощин Monoaminooxidase inhibitors, therapeutic agent and pharmaceutical composition
WO2011029920A1 (en) 2009-09-11 2011-03-17 Probiodrug Ag Heterocylcic derivatives as inhibitors of glutaminyl cyclase
WO2011107530A2 (en) 2010-03-03 2011-09-09 Probiodrug Ag Novel inhibitors
CA2789440A1 (en) 2010-03-10 2011-09-15 Probiodrug Ag Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
EP2560953B1 (en) 2010-04-21 2016-01-06 Probiodrug AG Inhibitors of glutaminyl cyclase
US8530670B2 (en) 2011-03-16 2013-09-10 Probiodrug Ag Inhibitors
EP3461819A1 (en) 2017-09-29 2019-04-03 Probiodrug AG Inhibitors of glutaminyl cyclase

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19533772C1 (en) * 1995-09-12 1998-01-02 Hexal Ag Tacrine / Selegiline patch
US6262111B1 (en) * 1997-05-21 2001-07-17 Sloan-Kettering Institute For Cancer Research Method for increasing the concentration of ascorbic acid in brain tissues of a subject
US6242473B1 (en) * 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage

Also Published As

Publication number Publication date
WO2004089351A3 (en) 2005-02-17
WO2004089351A2 (en) 2004-10-21

Similar Documents

Publication Publication Date Title
GB2398810B (en) Well treatment method and system
PL378368A1 (en) Compositions and methods for combination antiviral therapy
AU2003282580A8 (en) Contrast therapy system and method
EP1646318A4 (en) Adjustable line locks and methods
EP1694395A4 (en) Sleep guidance system and related methods
GB0111872D0 (en) Therapeutic agents and methods
HK1097256A1 (en) Pyrizdazine derivatives and their use as therapeutic agents
AU2003203029A8 (en) Improved health-related devices and methods
GB0206876D0 (en) Therapeutic agents
PL223344B1 (en) Therapeutic foam
GB0225474D0 (en) Therapeutic agents
ZA200506408B (en) Parazoles and methods of making and using the same
PL380527A1 (en) Anti-igfr1 antibody therapeutic combinations
GB0212885D0 (en) Therapeutic epitopes and uses thereof
EP1689485A4 (en) Cardioelectromagnetic treatment
GB0822148D0 (en) Methods and apparatus
AU2003207356A1 (en) Therapeutic method and apparatus
GB0230087D0 (en) Therapeutic agents
EP1597921A4 (en) Paging methods and apparatus
EP1572080A4 (en) Fgf variants and methods for use thereof
GB0201179D0 (en) Therapeutic agents
IL174994D0 (en) Pyrimidin - 4 - yl - 3, 4 - thione compounds and their use in therapy
ZA200603882B (en) Substituted benzimidazole-, benztriazole-, and benzimidazolone-O-glucosides
AU156617S (en) Stimulation device
EP1662993A4 (en) Bioimpedance methods and apparatus

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)